K

W

Woodline Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

C
Caris Life Sciences

Precision medicine • Molecular profiling

Woodline logo
Perceptive Advisors logo
Millennium Management logo
Ghisallo logo

Caris Life Sciences specializes in precision medicine through comprehensive molecular profiling and advanced AI technologies.

Equity
$168M
04/07/2025
Article
B
Blue Earth Therapeutics

Radioligand therapies • PSMA-targeted

Soleus Capital logo
Sands Capital Management logo
Woodline Partners logo
PBM Capital logo

Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.

Series A
$76.5M
11/12/2024
Article
F
Formo

Fermentation • Animal-free cheese

Woodline Partners logo
The Nature Conservancy logo
Seven Ventures logo
Sazaby League logo

Formo is a Berlin-based startup that produces animal-free cheese using micro fermentation of Koji proteins.

Series B
$61M
09/10/2024
Article
O
OrsoBio

Biopharmaceutical • Clinical-stage

Ascenta Capital logo
Woodline Partners logo
Samsara Biocapital logo
NuevaBio logo

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Series B
$67M
09/06/2024
Article
O
Odyssey Therapeutics

Biotechnology • Immunomodulators

Woodline Partners logo
Walleye Capital logo
Leerink Partners logo
The Global BioAccess Fund logo

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

Series C
$101M
12/05/2023
Article